CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Shanghai OPM Biosciences Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Shanghai OPM Biosciences Co Ltd
Block 28
Lane 908, Ziping Road, Pudong New Aera
Phone: +86 2120780178p:+86 2120780178 SHANGHAI, SHA  201321  China Ticker: 688293688293
Business Summary
Shanghai OPM Biosciences Co Ltd is a China-based company mainly engaged in cell culture products and services. The Company's main business involves two application areas: cell culture medium series products and biopharmaceutical contract development and production services. The Company's cell culture medium series products are widely used in the production of biological products such as protein/antibody production, vaccine production, cell therapy/gene therapy, and others. The Company's antibody drug development contract development and manufacturing organization (CDMO) service platform is committed to providing domestic and foreign customers with full-process services from antibody engineering humanization screening, cell line construction, process development to pilot production and clinical I&II phase sample production.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager ZhihuaXiao 49 12/1/2013 12/1/2013
Chief Financial Officer, Deputy General Manager, Director LiangpingNi 40 10/30/2024 5/1/2019
Deputy General Manager, Director, Chief Research and Development Officer YunfenHe 44 7/1/2016 7/1/2016
5 additional Officers and Directors records available in full report.

General Information
Number of Employees: 285 (As of 12/31/2023)
Outstanding Shares: 114,772,460 (As of 10/29/2024)
Shareholders: 3,470
Stock Exchange: SHA
Fax Number: +86 2168101069


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 22, 2024